DNA & Genetics Novartis, UNP, Launch Up-to-$1.8B+ Macrocyclic Peptide PartnershipBy adminFebruary 18, 20260 Novartis will apply Unnatural Products (UNP)’s artificial intelligence (AI)-guided macrocyclic peptide platform to develop next-generation cardiovascular disease therapeutics, through a…
DNA & Genetics 1910 Unlocks Macrocyclic Peptide Drugs Using PEGASUS AI ModelBy adminJanuary 6, 20260 PEGASUS leverages multi-modal data streams to learn the rules of macrocyclic peptide permeability [1910] 1910 is on a mission to…
